cost of prevention or treatment strategies, such as influenza vaccination programmes, may be measured using cost–effectiveness analyses or cost–benefit analyses. These analyses of influenza-related health-care interventions measure whether the benefits derived from the intervention are worth the cost of undertaking the intervention.